Followers | 39 |
Posts | 1624 |
Boards Moderated | 0 |
Alias Born | 04/17/2012 |
Friday, February 13, 2015 12:53:47 PM
If you spend just a few minutes looking at the management and the boards past track record and accomplishments, it's not difficult to see where they may eventually be going with this.
While they have the DenerveX device that is targeted at a very large market, specifically Facet Joint Syndrome which I believe encompasses about 30% of all lower back pain, they also indicate they intend to make strategic acquisitions.
Makes perfect sense because when you look at the fact they have Dr. Andrews and other world renowned physicians on the board of directors, you could envision them providing an almost unlimited amount of opportunities for the company to consider. Because of who their board members are, they may get a first look at some of the best medtech opportunities in existence.
Bottom line, because of who is involved, there should be no shortage of potential "first look" opportunities being funneled in their deal pipeline. At some point, one could envision some of those opportunities, post being thoroughly vetted, coming out the other end in the form of some potential value creation.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM